Valuation: ViGenCell Inc.

Market Cap 200B 149M 132M 123M 113M 212M 14.34B 214M 1.5B 580M 7.31B 559M 547M 23.57B P/E 2023
-6.24x
P/E 2024 -3.42x
Enterprise Value 162B 121M 108M 100M 91.45M 172M 11.65B 174M 1.21B 471M 5.94B 454M 444M 19.15B EV / Sales 2023
-
EV / Sales 2024 38,429,949x
Free-Float
73.87%
Yield 2023 *
-
Yield 2024 -
1 day-0.68%
1 week+1.57%
Current month+0.87%
1 month-5.99%
3 months+1.22%
6 months+16.43%
Current year-40.41%
1 week 5,450
Extreme 5450
6,660
1 month 5,450
Extreme 5450
7,000
Current year 4,320
Extreme 4320
14,400
1 year 3,070
Extreme 3070
17,360
3 years 2,305
Extreme 2305
17,360
5 years 2,305
Extreme 2305
21,975
10 years 2,305
Extreme 2305
39,000
Manager TitleAgeSince
Chief Executive Officer 68 -
Corporate Officer/Principal 48 2025-03-26
Director TitleAgeSince
Director/Board Member 68 2025-03-26
Director/Board Member 48 2025-03-26
Director/Board Member 55 2025-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/24 Exercice 35,000 0.1826%
4/30/24 Exercice

Director

63,000 0.3287%
4/30/24 Don 40,440 0.2110%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%+1.57%+62.75%+6.61% 88.43M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.27%-0.46%+55.22%+108.91% 39.06B
Weighted average by Cap. +0.12%-0.84%+58.77%+129.88%

Financials

2023 2024
Net sales - 278.95 0.21 0.18 0.17 0.16 0.3 20.01 0.3 2.09 0.81 10.2 0.78 0.76 32.89
Net income -17.88B -13.32M -11.83M -11.03M -10.06M -18.97M -1.28B -19.14M -134M -51.86M -654M -49.98M -48.91M -2.11B -14.06B -10.47M -9.3M -8.67M -7.91M -14.91M -1.01B -15.05M -105M -40.78M -514M -39.3M -38.46M -1.66B
Net Debt -45.96B -34.24M -30.43M -28.36M -25.88M -48.77M -3.3B -49.23M -344M -133M -1.68B -129M -126M -5.42B -37.44B -27.89M -24.78M -23.1M -21.08M -39.72M -2.69B -40.1M -280M -109M -1.37B -105M -102M -4.41B
Logo ViGenCell Inc.
ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In addition, the Company is engaged in the provision of vitier platform as an antigen-specific killing t cell treatment, viranger platform as a gammadelta t cell gene therapy and vimedier platform-based technology as a myeloid suppressor cell therapy derived from umbilical cord blood. It is engaged in the research and development of new drugs such as acute myeloid leukemia (AML) and glioblastoma.
Employees
-
Date Price Change Volume
26-10-02 ₩5,810.00 -0.68% 48,268
26-10-01 ₩5,850.00 +1.56% 115,179
26-09-30 ₩5,760.00 +3.97% 82,058
26-09-29 ₩5,540.00 -3.99% 98,823
  1. Stock Market
  2. Stocks
  3. A308080 Stock